Article Details

FDA clears IND application for stem cell therapy to treat AML

Retrieved on: 2021-01-14 19:30:00

Tags for this article:

Click the tags to see associated articles and topics

FDA clears IND application for stem cell therapy to treat AML. View article details on hiswai:

Excerpt

VOR33 (Vor Biopharma) is a hematopoietic stem cell therapy that is genetically engineered to lack the CD33 protein. Removal of this protein allows for ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up